LEGN
OtherLegend Biotech Corp
$28.96+0.45 (+1.58%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving LEGN Today?
No stock-specific AI insight has been generated for LEGN yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$5.4B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume3.5M
Avg Volume (10D)—
Shares Outstanding185.0M
LEGN News
20 articles- Is Legend Biotech (LEGN) Pricing Reflect Recent Share Rebound Or Longer Term SetbacksYahoo Finance·May 6, 2026
- Is Legend Biotech’s Expanded Scientific Board Quietly Redefining Its Long-Term CAR-T Strategy (LEGN)?Yahoo Finance·May 5, 2026
- Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million?Motley Fool·May 5, 2026
- Matthews Just Slashed Its Futu Position -- Here’s Why That MattersMotley Fool·May 5, 2026
- Legend Biotech Expands Scientific Advisory Expertise to Inform Future GrowthYahoo Finance·May 4, 2026
- H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)Yahoo Finance·Apr 29, 2026
- Legend Biotech to Host Investor Conference Call on First Quarter 2026 ResultsYahoo Finance·Apr 28, 2026
- Legend Biotech CARVYKTI Milestones Contrast With Mixed Long Term Share ReturnsYahoo Finance·Apr 22, 2026
- Legend Biotech (LEGN) Moves 18.4% Higher: Will This Strength Last?Yahoo Finance·Apr 21, 2026
- Legend Biotech (LEGN) Gets Bullish Ratings, PT Hike, Soars 18%Yahoo Finance·Apr 21, 2026
- Why Legend Biotech Stock Crushed the Market on MondayThe Motley Fool·Apr 20, 2026
- Is Legend Biotech (LEGN) One of the Overlooked Growth Stocks to Buy Now?Yahoo Finance·Apr 19, 2026
- How The Legend Biotech (LEGN) Story Is Shifting As Analyst Expectations ResetYahoo Finance·Apr 4, 2026
- Legend Biotech (LEGN) Q2 2025 Earnings TranscriptMotley Fool·Apr 1, 2026
- Legend Biotech (LEGN) Q4 2024 Earnings TranscriptMotley Fool·Apr 1, 2026
- Legend Biotech (LEGN) Q1 2025 Earnings TranscriptMotley Fool·Apr 1, 2026
- RBC Capital Cuts PT on Legend Biotech Corporation (LEGN) to $62 From $66 – Here’s WhyYahoo Finance·Mar 31, 2026
- Assessing Legend Biotech (LEGN) Valuation After Recent Share Price Moves And Profitability NarrativeYahoo Finance·Mar 26, 2026
- Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition TargetsYahoo Finance·Mar 25, 2026
- This Fintech Stock Is Up 21% in a Year as Profits Surge, but One Fund's Nearly $300 Million Sale Cut Its Stake in HalfMotley Fool·Mar 19, 2026
All 20 articles loaded
Price Data
Open$23.41
Previous Close$28.51
Day High$23.70
Day Low$23.01
52 Week High—
52 Week Low—
Fundamentals
Market Cap$5.4B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume3.5M
Avg Volume (10D)—
Shares Outstanding185.0M
About Legend Biotech Corp
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SIC—
CIK—
Composite FIGI—
Share Class FIGI—